These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

600 related items for PubMed ID: 9331279

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunologic privilege evoked by histoincompatible intracameral retinal transplants.
    Jiang LQ, Streilein JW.
    Reg Immunol; ; 3(3):121-30. PubMed ID: 2098067
    [Abstract] [Full Text] [Related]

  • 3. Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival.
    Niederkorn JY, Mayhew E, Mellon J, Hegde S.
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2674-81. PubMed ID: 15277491
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
    Yamada J, Zhu SN, Streilein JW, Dana MR.
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
    [Abstract] [Full Text] [Related]

  • 5. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
    Yamada J, Streilein JW.
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
    [Abstract] [Full Text] [Related]

  • 6. Unconventional rejection of neural retinal allografts implanted into the immunologically privileged site of the eye.
    Jiang LQ, Jorquera M, Streilein JW, Ishioka M.
    Transplantation; 1995 Apr 27; 59(8):1201-7. PubMed ID: 7732567
    [Abstract] [Full Text] [Related]

  • 7. Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts.
    Jiang LQ, Jorquera M, Streilein JW.
    Invest Ophthalmol Vis Sci; 1993 Nov 27; 34(12):3347-54. PubMed ID: 8225870
    [Abstract] [Full Text] [Related]

  • 8. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
    Yao YF, Inoue Y, Miyazaki D, Hara Y, Shimomura Y, Tano Y, Ohashi Y.
    Invest Ophthalmol Vis Sci; 1997 Feb 27; 38(2):292-300. PubMed ID: 9040461
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunity and immune privilege elicited by cultured retinal pigment epithelial cell transplants.
    Grisanti S, Ishioka M, Kosiewicz M, Jiang LQ.
    Invest Ophthalmol Vis Sci; 1997 Jul 27; 38(8):1619-26. PubMed ID: 9224290
    [Abstract] [Full Text] [Related]

  • 11. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y, Ksander BR, Streilein JW.
    Invest Ophthalmol Vis Sci; 1995 Oct 27; 36(11):2176-85. PubMed ID: 7558710
    [Abstract] [Full Text] [Related]

  • 12. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J, Kurimoto I, Streilein JW.
    Invest Ophthalmol Vis Sci; 1999 Oct 27; 40(11):2614-21. PubMed ID: 10509657
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells.
    Streilein JW, Niederkorn JY.
    J Immunol; 1985 Mar 27; 134(3):1381-7. PubMed ID: 3155766
    [Abstract] [Full Text] [Related]

  • 14. Evidence that retinal pigment epithelium functions as an immune-privileged tissue.
    Wenkel H, Streilein JW.
    Invest Ophthalmol Vis Sci; 2000 Oct 27; 41(11):3467-73. PubMed ID: 11006240
    [Abstract] [Full Text] [Related]

  • 15. Anterior chamber-associated immune deviation promotes corneal allograft survival.
    Niederkorn JY, Mellon J.
    Invest Ophthalmol Vis Sci; 1996 Dec 27; 37(13):2700-7. PubMed ID: 8977485
    [Abstract] [Full Text] [Related]

  • 16. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts.
    Sonoda A, Sonoda Y, Muramatu R, Streilein JW, Usui M.
    Invest Ophthalmol Vis Sci; 2000 Mar 27; 41(3):790-8. PubMed ID: 10711695
    [Abstract] [Full Text] [Related]

  • 17. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
    Shi W, Xie L, Wang S.
    Zhonghua Yan Ke Za Zhi; 2002 Aug 27; 38(8):502-5. PubMed ID: 12410993
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity and antigenicity of allogeneic amniotic epithelial transplants grafted to the cornea, conjunctiva, and anterior chamber.
    Wang M, Yoshida A, Kawashima H, Ishizaki M, Takahashi H, Hori J.
    Invest Ophthalmol Vis Sci; 2006 Apr 27; 47(4):1522-32. PubMed ID: 16565388
    [Abstract] [Full Text] [Related]

  • 19. Contribution of microglia as passenger leukocytes to the fate of intraocular neuronal retinal grafts.
    Ma N, Streilein JW.
    Invest Ophthalmol Vis Sci; 1998 Nov 27; 39(12):2384-93. PubMed ID: 9804147
    [Abstract] [Full Text] [Related]

  • 20. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts.
    Sonoda Y, Streilein JW.
    J Immunol; 1993 Mar 01; 150(5):1727-34. PubMed ID: 8436812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.